Article
Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
9 Apr 2024
Abstract excerpt
Current clinical guidelines recommend mismatch repair (MMR) protein immunohistochemistry (IHC) or molecular microsatellite instability (MSI) tests as predictive markers of immunotherapies. Most of the pathological guidelines consider MMR protein IHC as the gold standard test to identify cancers with MMR deficiency and recommend molecular MSI tests only in special circumstances or to screen for Lynch syndrome....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
